BioLargo ( (BLGO) ) has released its Q4 earnings. Here is a breakdown of the information BioLargo presented to its investors.
BioLargo, Inc. is a cleantech and life sciences company that develops and commercializes sustainable technologies for environmental challenges, focusing on areas such as water treatment, odor control, and energy storage. In its latest annual report, BioLargo announced a record 45% increase in revenues for 2024, marking the tenth consecutive year of growth. The company generated over $5 million in cash from its odor control products, reducing its reliance on equity financing. Key financial metrics include a net loss of $4.3 million, a decrease from the previous year, and a significant reduction in stock issuance. BioLargo’s Clyra Medical division is advancing towards a national rollout of its surgical products, having completed a successful inspection with a distribution partner. The company ended the year with $6 million in stockholders’ equity and $3.5 million in cash. Looking ahead, BioLargo aims to continue expanding its product offerings and market reach, leveraging its innovative technologies to address global environmental challenges.